University of Sydney: Oral Insulin Drug Achieves a Critical Milestone
September 10, 2026
September 10, 2026
SYDNEY, Australia, Sept. 10 (TNSjou) -- The University of Sydney issued the following news:
* * *
10 September 2026
Oral insulin drug achieves a critical milestone
First-in-Humans study makes Endo Axiom a clinical-stage company
-
University of Sydney biotechnology spinout Endo Axiom is conducting its first study in human subjects to assess the safety and tolerability of different doses of oral insulin in healthy volunt . . .
* * *
10 September 2026
Oral insulin drug achieves a critical milestone
First-in-Humans study makes Endo Axiom a clinical-stage company
-
University of Sydney biotechnology spinout Endo Axiom is conducting its first study in human subjects to assess the safety and tolerability of different doses of oral insulin in healthy volunt . . .